Ironwood Pharmaceuticals (IRWD) Net Shares Issued and Repurchased (2011 - 2025)

Ironwood Pharmaceuticals has disclosed Net Shares Issued and Repurchased across 15 years of filings, most recently posting $1.1 million for Q4 2025.

• In Q4 2025, Net Shares Issued and Repurchased rose 142.48% year-over-year to $1.1 million; the TTM figure through Dec 2025 stood at $1.1 million (up 142.48% YoY), while the FY2025 annual figure was $1.1 million, up 142.48% from the prior year.
• Net Shares Issued and Repurchased came in at $1.1 million for Q4 2025 at Ironwood Pharmaceuticals, up from $470626.0 in the prior quarter.
• In the past five years, Net Shares Issued and Repurchased ranged from a high of $2.4 million in Q4 2021 to a low of $470626.0 in Q4 2024.
• Average Net Shares Issued and Repurchased over 5 years is $1.3 million, with a median of $1.1 million recorded in 2025.
• Year-over-year, Net Shares Issued and Repurchased sank 43.96% in 2024 and soared 142.48% in 2025.
• Over 5 years, Net Shares Issued and Repurchased stood at $2.4 million in 2021, then sank by 37.62% to $1.5 million in 2022, then plunged by 43.64% to $839857.0 in 2023, then slumped by 43.96% to $470626.0 in 2024, then soared by 142.48% to $1.1 million in 2025.
• Per Business Quant data, the three most recent Net Shares Issued and Repurchased figures were $1.1 million in Q4 2025, $470626.0 in Q4 2024, and $839857.0 in Q4 2023.